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Neuronal Nogo-A modulates growth cone motility via
Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system
Abstract
Nogo-A has been extensively studied as a myelin-associated neurite outgrowth inhibitor in the lesioned
adult central nervous system. However, its role in the intact central nervous system has not yet been
clarified. Analysis of the intact adult nervous system of C57BL/6 Nogo-A knock-out (KO) versus
wild-type (WT) mice by a combined two-dimensional gel electrophoresis and isotope-coded affinity
tagging approach revealed regulation of cytoskeleton-, transport-, and signaling growth-related proteins,
pointing to regulation of the actin cytoskeleton, the neuronal growth machinery, and in particular the
Rho-GTPase/LIMK1/cofilin pathway. Nogo-A KO adult neurons showed enlarged, more motile growth
cones compared with WT neurons. The phenotype was reproduced by acute in vitro neutralization of
neuronal Nogo-A. LIMK1 phosphorylation was increased in Nogo-A KO growth cones, and its
reduction caused the decrease of KO growth cone motility to WT levels. Our study suggests that in the
unlesioned adult nervous system, neuronal Nogo-A can restrict neuronal growth through negative
modulation of growth cone motility.
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Nogo-A has been extensively studied as 
myelin-associated neurite outgrowth inhibitor 
in the lesioned adult CNS. However, its role in 
the intact CNS has not yet been clarified. 
Analysis of the intact adult nervous system of 
C57Bl/6 Nogo-A knockout versus wild type 
mice by a combined 2DE and ICAT approach 
revealed regulation of cytoskeleton, transport 
and signaling growth related proteins, 
pointing to the regulation of the actin 
cytoskeleton and of the neuronal growth 
machinery, and in particular of the Rho-
GTPases/LIMK1/cofilin pathway. Adult 
Nogo-A KO neurons showed enlarged more 
motile growth cones, when compared to WT. 
The phenotype was reproduced by acute in 
vitro neutralization of neuronal Nogo-A. 
LIMK1 phosphorylation was increased in 
Nogo-A KO growth cones and its reduction 
caused the decrease of KO growth cone 
motility to WT level. Our study suggests that 
in the unlesioned adult nervous system 
neuronal Nogo-A can restrict neuronal 
growth through negative modulation of 
growth cone motility.  
 
During postnatal development central nervous 
system (CNS) neurons loose their ability to 
regenerate in part due to the presence of neurite 
outgrowth inhibitors, e.g. in myelin or in the glial 
scar (Fawcett, 2006; Schwab, 2004). A number 
of molecules with suggested growth inhibitory 
activity are present in the adult CNS: Nogo-A, 
oligodendrocyte myelin glycoprotein (OMgp), 
myelin-associated glycoprotein (MAG), 
repulsive guidance molecule-RGM (Benowitz 
and Yin, 2007; Schwab, 2004; Yiu and He, 
2006) as well as certain Ephrins (Fabes et al., 
2006; Figueroa et al., 2006), Semaphorins (de 
Wit and Verhaagen, 2003; Kaneko et al., 2006; 
Pasterkamp and Verhaagen, 2006) and 
proteoglycans (Fawcett, 2006). Nogo-A has been 
extensively studied for its role in inhibiting 
axonal regeneration as well as compensatory 
fiber growth in the injured adult CNS in vivo 
(Cafferty and Strittmatter, 2006; Schwab, 2004; 
Yiu and He, 2006). Neutralization of Nogo-A 
through in vivo application of function blocking 
antibodies induces neuronal growth after spinal 
cord or brain injury in adult rodents as well as 
primates (Freund et al., 2006; Schwab, 2004). A 
moderate increase of regeneration and 
compensatory fiber growth after lesion has been 
also observed in Nogo-A knockout (KO) mice, 
with a different degree depending on intrinsic 
genetic differences of different analyzed mouse 
strains (Cafferty and Strittmatter, 2006; Dimou et 
al., 2006; Kim et al., 2003; Simonen et al., 2003; 
Zheng et al., 2003). In the adult CNS, Nogo-A is 
predominantly found in the innermost, adaxonal 
as well as in the outermost myelin membrane and 
in oligodendrocytes (Huber et al, 2002; Wang et 
al, 2002a). During development, Nogo-A is 
expressed in neurons where it has been suggested 
to play a role in neuronal migration and cortical 
development (Mingorance-Le Meur et al., 2007) 
as well as to regulate synaptic plasticity (Aloy et 
al., 2006; Jin et al., 2003; Liu et al., 2003). 
Neuronal expression of Nogo-A is 
downregulated following the onset of 
myelination but persists at higher levels in 
particular neuronal populations, like in the 
hippocampus (Huber et al., 2002; Trifunovski et 
al., 2006), olfactory bulb, deep cerebellar nuclei, 
spinal motor neurons (Nyatia and Lang, 2007) 
and in dorsal root ganglia (DRG) (Dodd et al., 
2005). The possible roles of neuronal Nogo-A in 
the intact adult CNS have not been studied in 
details. It has been shown that its neutralization 
in vivo in intact adult rats produced a transitory 
growth response of Purkinje axons and of the 
corticospinal tract (Bareyre et al., 2002; Buffo et 
al., 2000; Gianola et al., 2003).  
In the last few years, the application of systems 
biology approaches based on large-scale analysis 
of proteins have been successfully applied to 
complex biological networks, e.g. for the 
analysis of neurodegenerative disorders and 
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infections (Han et al., 2008; Minn et al., 2005). 
In the present study we used systems biology 
profiling, based on two proteomic approaches 
(two-dimensional gel electrophoresis (2DE) and 
isotope-coded affinity tagging (ICAT)) to 
address the role of Nogo-A in the unlesioned 
adult central nervous system. We compared the 
adult central nervous system of C57Bl/6 naïve, 
unlesioned, Nogo-A KO and wild type (WT) 
mice and, using a combination of approaches, we 
report that the depletion of Nogo-A or functional 
blockade of neuronal Nogo-A in the adult as well 
as postnatal intact nervous system causes the re-
organization of the cytoskeletal growth cone 
machinery on both the molecular and the 
morphological level and that the LIMK1/cofilin 
phosphorylation state is critical for this process.  
 
EXPERIMENTAL PROCEDURES 
 
Animals - Male C57Bl/6 Nogo-A KO mice with 
a strain purity >99.98% and backcrossed for 
more than 10 generations (Dimou et al., 2006) 
and male C57Bl/6 WT mice were used. All 
animal experiments were performed with the 
approval of and in strict accordance with the 
guidelines of the Zurich Cantonal Veterinary 
office. All efforts were made to minimize animal 
suffering and to reduce the number of animals 
required. 
Antibodies - Rabbit anti-cofilin (WB 1:1000, 
Chemicon), Rabbit anti-phospho-cofilin Ser3 
(WB 1:1000, Chemicon), Mouse anti-GAPDH 
(WB 1:15000, Abcam), Rabbit anti-LIM kinase 1 
(WB 1:1000, ICC 1:100 Abcam), Mouse anti-
Nogo-A 11C7 (WB 1:15000; neutralization 
assay 3ug/ml, Novartis), Rabbit anti-phospho-
Lim kinase 1 T508 (WB 1:1000, ICC 1:150 
Abcam), Rabbit anti-beta tubulin (ICC 1:150, 
Abcam), Mouse anti-beta-III Tubulin (ICC 
1:2000, Promega), Goat anti-Mouse IgG HRP 
coupled (WB 1:15000, Pierce), Goat anti-Rabbit 
IgG H+L Cy3 coupled (ICC 1:3000, Jackson 
Laboratories), Donkey anti-Rabbit IgG HRP 
coupled (WB 1:10000, Pierce), Rabbit IgG (WB 
1:1000, Pierce), Phalloidin-Alexa 488 (ICC 1:40, 
Molecular Probes), Rhothekin–RBD protein 
GST tagged (1:100, Cytoskeleton), Rabbit pAb 
anti-GST (1: 1000, Abcam).  
2D Gel electrophoresis - Lumbar spinal cord of 3 
adult Nogo-A KO and WT mice were dissected 
and transferred to CHAPS lysis buffer (50mM 
NaH2PO4 pH8.0, 150mM NaCl, 0.5% CHAPS, 
protease inhibitor cocktail (Roche) ) on ice. 
Tissues were disrupted using a rotor-stator 
homogenizer. After 30’ on ice, samples were 
centrifuged (15’, 2000g, 4°C) and total protein 
concentration of the supernatant was determined 
using a NanoDrop Spectrophotometer system 
(NanoDrop Technologies). Each sample was 
processed independently to permit evaluation of 
individual differences. 150ug of proteins/sample 
were loaded on 3-10 and 4-7 IPG strips 
(Amersham Bioscience) in rehydration solution 
(Urea 7M, Thiourea 2M, 2% CHAPS, 0.3% 
DTT, 3-10 or 4-7 IPGbuffer (Amersham 
Bioscience)). IPG strips were refocused and 
transferred on 11% SDS-PAGE gels. Second 
dimension was resolved in SDS-electrophoresis 
buffer in an EttanDALTtwelve system (GE 
Healthcare) according to system instructions. 
Protein spot staining was performed with 
SyproRuby (Molecular probes, Invitrogen) 
according to manufacturer’s protocol. Images 
were captured using a Typhoon 9400 scanner 
(GE Healthcare) and analyzed with 
ProteomWeaver software (Version 2.2; 
Definiens). A protein target excision list of the 
regulated spots (1-way ANOVA, p≤0.05) was 
generated, spots excised with a GelPix Spot 
Picking Robot (Genetix) and processed for in-gel 
digestion, extraction and purification of the 
peptides as well as spotting onto MALDI target 
plates using a TECAN Genesis ProTeam 150 
Digester/Spotter running under Gemini software. 
Samples were analyzed on a 4700 Proteomics 
Analyzer MALDI TOF/TOF system (Applied 
Biosystems). All mass spectra were recorded in 
positive reflector mode, and they were generated 
by accumulating data from 5000 laser pulses. Up 
to five spectral peaks per spot were included in 
the list for the acquisition of MS/MS spectra. 
GPS (Global Proteome Server) Explorer 
Software version 2.0 (Applied Biosystems) was 
used for submitting MS and MS/MS data for 
database searching. Mascot (Matrix Science) was 
utilized as the search engine. A mouse protein 
database from the European Bioinformatics 
Institute (33081 sequences; release date, March 
19 2005) was used. 
ICAT - Lumbar spinal cords of 3 adult Nogo-A 
KO as well as WT mice were dissected. Due to 
technical restrictions, tissues from the same 
genotype were pooled, transferred to lysis buffer 
(5mM EDTA, 50mM Tris-HCl pH 8.3, 1% 
Rapigest (Waters Corporation)) and disrupted 
using a rotor-stator homogenizer. After 30’ on 
ice, samples were centrifuged (15’, 2000g, 4°C) 
and total protein concentration of the supernatant 
was determined using a NanoDrop 
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Spectrophotometer system (NanoDrop 
Technologies). 600ug of both samples were 
reduced with tributylphosphine and labeled with 
ICAT reagents (Applied Biosystems) 2hrs at 
37ºC. After quenching with DTT, samples were 
combined and digested with trypsin overnight at 
37°C. The peptide mixture was fractionated by 
HPLC in a KCl gradient. Biotinylated peptides 
were purified on Applied Biosystems ICAT 
avidin cartridges according to the manufacturer’s 
protocol. Fractions were dried by speed-
vacuuming, biotin cleaved with Applied 
Biosystems cleaving reagents and cleaned with 
Sep-Pak Cartridges (Vac C18 1cc – Waters 
Corporation). ICAT peptides were analyzed by 
nano-LC-MS using an LTQ-FTTM mass 
spectrometer (Thermo Electron). Peptides were 
separated on a nano-HPLC (Agilent) online prior 
to MS analysis on a home made C18 reversed 
phase column (Magic 5um, 100A C18 AQ, 
Michrom) using an acetonitrile/water system at a 
flow rate of 200 nl/min. Tandem mass spectra 
were acquired in a data dependent manner. 
Typically, 4 MS/MS were performed after each 
high accuracy spectral acquisition range survey. 
Data analysis was performed through the 
Sisyphus platform (developed by the group of 
Dr. Wollscheid), ProteinProphet probability 
score and ASAP Ratio were applied. 
Dissociated DRGs - DRG from 3 P0 and 3 adult 
KO and WT mice per experiment were dissected 
and trypsinized at 37°C. After trituration cells 
were filtered, plated at low density (1.5 x 104, 
glass coverslips coated with 20ug/ml PLL and 
5ug/ml laminin) and cultured (L15 with L-
Glutamine, N1 additives, 50ug/ml NGF, 0.25% 
NaHCO3, at 5% CO2 and 37°C) for 6hr (P0) or 
14hrs or 1, 2 and 3 DIV (adult). Each experiment 
was repeated 3 times with 4 experimental 
replicates each, unless differently stated. 
Parameters of neuronal morphology (branching 
points, number of neurites, number of filopodia, 
lamellipodia area, lamellipodia perimeter, 
tubulin-core area) were measured through 
ImageJ software (NIH) in 20 neurons per 
experiment, in 3 independent experiments, for a 
total of 60 neurons. Percentage of enlarged 
growth cones and growth cone morphology was 
assessed for all growth cones of the total number 
of neurons in 3 independent experiments. Total 
length of the neurite tree was measured through 
Metamorph software (Molecular Devices). 
Parameters of neuronal morphology for P0 
dissociated DRG were measured through ImageJ 
software (NIH) in at least 10 neurons per 
coverslip in 4 coverslips (experimental 
replicates) in two separate experiments, for a 
total of at least 80 neurons. P0 neurons were 
manually traced through ImageJ software (NIH) 
using the NeuronJ plug-in (Meijering et al., 
2004). Data analysis was performed by Prism 4.0 
(GraphPad software).  
Nogo-A neutralization - 3ug/ml of highly 
purified mouse monoclonal 11C7 anti-Nogo-A 
antibody or of control highly purified mouse IgG 
antibody have been applied to adult Nogo-A KO 
and WT low density dissociated DRG neurons at 
plating time. Cells have been cultured for 14 
hours. Each experiment was repeated 3 times, 
with 4 experimental replicates each. Percentage 
of enlarged growth cones was calculated for the 
total number of neurons in 3 independent 
experiments. Data analysis was performed by 
Prism 4.0 (GraphPad software). 
COS-7 cultures - Native COS7 cells were 
cultured o/n in DMEM, 10% FBS, gentamicin, 
then treated for 1 hour with increasing 
concentrations (5, 10, 20, 40 ug/ml) of S3- or the 
reverse-sequence control RV-peptide. 
PC12  cultures – PC12 cells were cultured for 3 
days in DMEM, 6% HS, 6% NCS, 1% 
Penicillin/Streptomicin. Following trypsinization 
cells were counted and plated on PLL coated 
coverslips (20ug/ml) at a 50000cells/100ul 
density in differentiating medium (DMEM, 1% 
BSA, 100ng/ml NGF). Cells were cultured for 48 
hours.  They were then treated for 1 hour with 
increasing concentrations (5, 10, 20, 40 ug/ml) of 
S3- or the reverse-sequence control RV-peptide. 
Retinal ganglion neurons cultures – 
Immortalized retinal ganglion neurons (RGC-5, 
provided by Dr. Krishnamoorthy, Dept of Cell 
Biol, University of Texas, USA) were grown for 
3 days in DMEM+glutamax (Gibco), 10% FBS, 
1% Penicillin/Streptomicin. Following 
trypsinization, cells were counted and plated on 
PLL coated coverslips (20ug/ml) at 
10000cells/100ul density. Cells were grown o/n 
and then treated for 1 hour with 20ug/ml of S3- 
or the reverse-sequence control RV-peptide. 
Time-lapse video microscopy - Adult dissociated 
DRG from adult Nogo-A KO and WT mice were 
cultured for 14hrs in 2-well Lab-Tek chambered 
coverglass (NalgeNunc). Following, samples 
were observed under a Leica WideField IRBE 
Microscope by phase contrast at 37ºC, 5% CO2, 
with a 100X oil immersion objective. Images 
were captured with a Hamamatsu camera using 
OpenLab 3.1.7 software (Improvision). At least 5 
KO as well as WT neurons were randomly 
 3
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on February 3, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
chosen and the largest growth cone of each of 
them imaged. 6 independent experiments have 
been performed. For each growth cone, 60 
images at intervals of 15 seconds were acquired, 
for a total real time of 15 minutes of recordings. 
Movies were further processed through OpenLab 
and QuickTime (Apple) (0.15s/frame). Statistical 
data analysis was performed by Prism 4.0 
(GraphPad software). For S3- and RV-peptide 
treatments, after 13 hours culturing, adult 
dissociated KO and WT DRGs were treated with 
20ug/ml peptide for 1hour and then imaged as 
above, with a 40X oil immersion objective. 
Immunoblotting - Spinal cords from 8 adult 
Nogo-A KO as well as WT mice were processed 
for protein lysate as for 2DE. Samples 
(30ug/lane) were resolved by 7-14% NuPAGE 
(Invitrogen), and transferred onto PVDF 
membranes. After blocking, incubation with 
primary antibodies at 4°C o/n followed. After 
washing, membranes were incubated with 
secondary antibodies. Proteins were detected by 
a chemiluminescent substrate (SuperSignal West 
Pico, Pierce Biotechnology)). Images were 
captured with Stella system (Agilent 
technologies). Densitometry was performed with 
AIDA software (Raytest). Data analysis was 
performed by Prism 4.0 (GraphPad software). 
Immunocytochemistry - Cells were fixed with 4% 
PFA for 15 min at RT and permeabilized (0.1% 
Triton X-100, 1XPBS). After blocking, cells 
were incubated for double staining with primary 
antibodies. Incubation with appropriate 
secondary antibody for 30 min and with DAPI 
followed. Activated Rho was detected by 
probing cells with the Rho-binding domain 
(RBD) from the Rho-GTP–interacting protein, 
rhotekin, tagged with. Antibodies against GST 
were subsequently used. Preparations were 
mounted in Mowiol/DABCO before examination 
under a conventional fluorescence microscope 
(Axioscope 2 mot plus, Zeiss). Imaging was 
performed using an AxioVision system. 
 
RESULTS 
 
Profiling of Nogo-A KO versus WT unlesioned 
adult mouse spinal cord by 2DE and ICAT - We 
analyzed the adult spinal cord of C57Bl/6 Nogo-
A KO versus WT mice by 2DE (pH 4-7 and pH 
3-10 isoelectrophocusing strips were both used to 
increase the number of identified regulated spots 
(Fig. 1, Supp. Fig. 1)) and ICAT (Fig. 2), 
followed by HPLC peptide separation and 
subsequent run and analysis through an LC-
MS/MS. With 2DE, 93 regulated spots were 
identified, corresponding to 62 different known 
proteins/protein subunits. 16 of the identified 
proteins were represented in more than one 
regulated spot, pointing to a different post-
translational modification state in Nogo-A KO 
compared to WT tissue (Table 1). Up- and down-
regulation were equally represented (51.6% up- 
and 48.4% down-regulated spots). Assignment to 
functional categories, on the basis of 
GeneOntology and literature mining, showed that 
the highest number of regulated proteins or spots 
fell into the category cytoskeleton (17%, 33%). 
The other major functional categories 
significantly represented (%proteins, %spots) 
were: neuroprotection (17%, 13%), metabolism 
(12%, 10%) and transport (7%, 6%) (Fig. 1).  
Only one regulated myelin protein was observed 
(myelin basic protein, 0.52 fold). The complete 
list of protein changes is shown in Supp. Table 1. 
The quantitative ICAT analysis allowed the 
identification of a high number of regulated 
proteins, in particular of hydrophobic membrane 
proteins, due to the avoidance of the 
loading/separation in a gel matrix. With a 
ProteinProphet probability score ≥0.9, 407 
proteins were identified (71.7% ≥2 unique 
peptides) (Fig. 2 A; Supp. Table 2) with a normal 
distribution around 1.19±0.02 (mean ratio) (Fig. 
2 B). All the ratios have been normalized to this 
value, assuming a correct mean ratio of 1.000, in 
order to correct for possible errors in protein 
quantification. 219 proteins showed a fold 
change ratio between 0.5 and 2 in Nogo-A KO 
versus WT spinal cord. Proteins outside of this 
interval were normally distributed in terms of up- 
(16.5%) and down-regulation (15.5%). 104 
proteins showed statistically significant 
regulation according to adjusted ASAPRatio and 
standard error (Supp. Table 2) and were 
categorized into functional categories using 
Panther v6.1 software (www.pantherdb.org) and 
literature mining (Fig. 2 C). The results reflected 
the ones observed with the 2DE approach: 
signaling (14%), metabolism (14%), transport 
(11%), cytoskeleton (9%) and neuroprotection 
(5%) were the major represented categories (Fig. 
2 C). 
Molecular reorganization of the neurite 
outgrowth machinery in the intact adult nervous 
system of Nogo-A KO mice - The category 
“cytoskeleton” was the one mainly represented in 
the changes found in our proteomic approach. 
With 2DE we observed a higher number of 
regulated spots (33%) than of proteins (17%) 
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(Fig. 1) speaking for an important role of 
posttranslational modifications in the regulation 
of the cytoskeleton in response to Nogo-A 
ablation. In addition to actin and tubulin 
isoforms, many of the differentially expressed 
proteins play an important role in actin and 
tubulin cytoskeleton remodeling (Table 1, Fig. 
3). Particularly interesting is cofilin previously 
suggested to be downstream of Nogo-A/NgR 
signaling (Hsieh et al., 2006); it showed two 
regulated spots: 0.79 (-1.27) and 1.70 fold 
respectively (Table 1), pointing to a diverse post-
translational modification state of this protein. 
Cofilin phosphorylation state, regulated by 
LIMK1, is known to affect actin cytoskeleton 
dynamics, growth cone motility and neurite 
outgrowth (Fig. 3). The changes in actin-binding 
proteins (myosin, tropomyosin) as well as actin 
itself (Table 1) suggested that the actin 
cytoskeleton was directly affected. In addition, 
neuronal intermediate filaments, e.g. peripehrin, 
neurofilament-68, and alpha-internexin, which 
are highly expressed during development and in 
early neurite formation, were also regulated, 
suggesting the whole neuronal cytoskeleton to be 
affected by the lack of Nogo-A (Table 1). This 
conclusion was supported by the high number of 
spots (12%) and proteins (15%) falling into the 
category of signaling molecules (Fig. 1), the 
majority of which belonged to pathways 
responsible for cytoskeleton rearrangements and 
neurite outgrowth control. Examples are: the 14-
3-3 family of proteins, known to interact with 
cofilin as well as with its major regulator 
LIMK1, and  Rho-GDP dissociation inhibitor 1, 
a key regulatory molecule of the Rho-GTPases 
signaling pathway (Table 1) which can upstream 
of LIMK1 affect its phosphorylation and, 
therefore, activity state.  
We observed also the down regulation of 
CRMP2, a protein playing a role in growth cone 
collapse (Quach et al., 2004) (Table 1).  
The comparison and integration of the ICAT data 
with the 2DE data permitted us to strengthen our 
observation of an important response at the level 
of the neuronal cytoskeleton and signaling 
machinery (Table 2, Fig. 2, and Fig. 3). 
Cytoskeletal proteins known to affect actin 
polymerization (F-actin capping protein 
0.69±0.15), neurite outgrowth (Microtubule-
associated protein RP/EB 3 1.81±0.59, 
Microtubule associated protein 2 2.05±0.62) or 
microtubule-dependent transport (dynein 
15.54±5.64) were shown to be regulated in a 
direction pointing to growth enhancement: down 
regulation of actin severing proteins and up 
regulation of motor as well as microtubular 
proteins. The total level of cofilin presented a 
slight downregulation (0.66±0.27) (Table 2). 
This technique only allowed quantifying total 
level of relative cofilin expression, while not 
permitting the discrimination between 
phosphorylated and unphosphorylated forms. 
Among the other regulated signaling proteins 
emerged again the 14-3-3 proteins (14-3-3 theta 
1.7±0.55, 14-3-3 eta 1.48±0.30, and 14-3-3 
gamma 1.28±0.25) as well as a member of the 
CRMP proteins (Dihydropyrimidinase-related 
protein 5 0.72±0.25). The Rho-GTPase signaling 
pathway was also affected (Rho-related GTP 
binding protein RhoB precursor 0.34±0.12, RAS-
related C3 botulinum substrate 1 (Rac1) 
0.63±0.23) (Table 2). All the observed regulated 
pathways are known to affect cytoskeleton 
dynamics and in particular point to the Rho-
GTPase signaling pathway, which can affect the 
phosphorylation state of LIMK1 which can in 
turn phosphorylate and inactivate cofilin 
(Bernard, 2007). As shown below, we observed 
an increase in cofilin phosphorylation. Therefore, 
the Rho-GTPase/LIMK1/cofilin signaling 
pathway is clearly a candidate in the regulation 
of neuronal cytoskeletal proteins in the absence 
of Nogo-A signaling in the intact adult CNS. 
Modulation of the Rho-GTP/LIMK1/cofilin 
pathway in the adult CNS and in adult 
dissociated DRG neurons from Nogo-A KO mice 
- Cofilin is an actin severing protein inactivated 
through phosphorylation. It can directly affect 
actin polymerization rate, actin filopodia 
formation, growth cone motility (Bernard, 2007; 
Endo et al, 2003) and, as recently shown, neurite 
outgrowth (Endo et al, 2007). The activation 
state of LIMK1 has been shown to play a key 
role in regulating the phosphorylation state of 
cofilin (Bernard, 2007). We tested the levels of 
total and phosphorylated cofilin and LIMK1 in 
the spinal cord of adult unlesioned Nogo-A KO 
compared to WT mice by western blots (Fig. 4 
A, B). Densitometry confirmed increased levels 
of phosphorylated, and therefore inactive, cofilin 
in Nogo-A KO mice. It also showed increased 
levels of phosphorylated, and therefore active, 
LIMK1. No change was detected in total protein 
levels. These data support a role of the LIMK1 
activation state in the regulation of cofilin 
phosphorylation and inactivation (Fig. 4 A, B) in 
the intact spinal cord of adult Nogo-A KO mice.  
To clarify if these changes could be ongoing in 
adult Nogo-A KO neurons, as a recent study 
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from Endo et al (2007) has shown that LIMK1 
regulates actin filament assembly at the tip of the 
growth cone of chick DRG neurons and as DRG 
neurons are one of the few populations of adult 
neurons with axons in the CNS which can be 
maintained in cultures, we analyzed by 
immunocytochemistry the levels of 
phosphorylated and total LIMK1 in the growth 
cones of adult Nogo-A KO as well as WT 
dissociated DRG neurons after 14hours in 
cultures (Fig. 5 A). Results show that the levels 
of phosphorylated LIMK1 are increased in the 
growth cones (KO = 1.46±0.16, WT = 1.0±0.08) 
of Nogo-A KO compared to WT neurons (Fig. 5 
A).  However, no change could be detected for 
the total level of expression of LIMK1 (KO = 
1.158±0.06, WT = 1.0±0.06) (Fig. 5 A). 
LIMK1 phosphorylation is regulated through 
activation of ROCK by Rho-GTP and of PAK1 
by Rac and Cdc42. Interestingly our proteomic 
data already pointed to a potential regulation of 
Rho-GTPases in the intact nervous system of 
Nogo-A KO mice. Nogo-A is up to now only 
known to affect RhoA activation. Therefore, we 
tested the level of Rho-GTP in vitro in Nogo-A 
KO and WT adult dissociated DRGs and could 
observe an upregulation of activated Rho in the 
growth cones of Nogo-A KO neurons (KO = 
1.56±0.1, WT = 1.0±0.04), pointing to its 
potential involvement in the increase of  LIMK1 
phosphorylation (Fig. 5 B). 
Adult neurons from Nogo-A KO mice show 
altered growth cone morphology and increased 
growth cone motility - The LIMK1/cofilin 
pathway, recently shown to directly affect 
neurite outgrowth and actin filopodia formation 
at the tip of the growth cone in chicken dorsal 
root ganglia (Endo et al, 2007), as well as the 
observed modulation of other signalling 
molecules participating in this pathway and/or 
known to affect cytoskeletal dynamics (14-3-3 
proteins, CRMPs, RhoGTPases) and the changed 
expression levels of several additional 
cytoskeleton and cytoskeleton binding proteins 
like dynein or myosin II, which have been 
suggested to increase neurite and growth cone 
motility when up regulated (Grabham et al, 2007; 
Sachdev et al, 2007; Medeiros et al, 2006), could 
influence the morphology and the dynamic 
aspects of the neuronal cytoskeleton of adult 
Nogo-A KO neurons (Fig. 3). Nogo-A KO adult 
dissociated DRG neurons, plated onto a poly-
lysine/laminin substrate and kept 14 hours in 
culture, did not show significant differences in 
the number of emitted neurites or in branching 
points when compared to WT (Suppl. Fig. 2). 
However, they showed a clear shift towards 
larger growth cones (≥100 um2) and a 
corresponding reduction in smaller (≤50 um2) 
compared to WT (Fig. 6 A). Taking the overall 
morphology and distribution of F-actin and 
microtubules into account, we categorized the 
growth cones into dystrophic (Tom et al, 2004), 
normal and enlarged (Fig. 6 A). The percentage 
of neurons presenting enlarged growth cones was 
significantly higher in Nogo-A KO dissociated 
DRG cultures (WT = 13.30±6.72%, KO = 
35±6.60%) (Fig. 6 A).  A more accurate analysis 
of the growth cones has shown that the increase 
in growth cone area is specifically due to an 
increase in the area covered by actin containing 
lamellipodia (KO = 2.28±0.16, WT = 1.0±0.19), 
while no difference could be observed in the 
tubulin containing core area (KO = 1.2±0.14, 
WT = 1.0±0.17). These data are reflected in the 
measured decrease of the percentage of tubulin 
core area over the total area of Nogo-A KO 
versus WT growth cones (KO = 0.61±0.03, WT 
= 1.0±0.05).  To test whether more F-actin 
polymerization could result in an increase of 
both lamellipodia and filopodia, we counted the 
number of filopodia per growth cone. No 
significant change was present in total filopodial 
number (KO = 0.99±0.07, WT = 1.0±0.08). 
However, due to the larger lamellipodial area, a 
decrease in the number of filopodia in relation to 
the perimeter of the growth cone was observed 
(KO = 0.47±0.03, WT = 1.0±0.16) (Fig. 6 B). 
To check for specificity of the observed 
morphological changes, we performed an 
additional set of experiments in which we 
specifically and acutely blocked Nogo-A, present 
on the cell membrane of adult DRGs (Dodd et 
al., 2005), in cultures by adding anti-Nogo-A 
specific antibodies (11C7; Fig. 7 A, B) to 
dissociated DRGs of WT mice. An IgG antibody 
was applied as control and adult Nogo-A KO 
dissociated DRGs were treated as well with both 
11C7 or IgG as additional controls (Fig. 7 B). 
The specific neutralization of Nogo-A 
reproduced the neuronal phenotype observed in 
Nogo-A KO neurons, showing an increase in the 
percentage of neurons with enlarged growth 
cones (Fig. 7 B), suggesting that the observed 
phenotype is specifically due to the lack of 
neuronal Nogo-A and not to additional 
compensating molecules, e.g. Nogo-B.  
Neuronal Nogo-A influences growth cone 
morphology also in newborn DRG neurons - To 
further understand if the lack of Nogo-A 
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signaling was affecting the growth cone 
machinery only of adult Nogo-A KO neurons or 
also during development, when Nogo-A 
expression is strictly neuronal, we dissociated 
DRG neurons from Nogo-A KO and WT 
newborn (P0) mice (Fig. 7 C). As in adult 
neurons, no significant difference was detected 
in the number of branch points (KO = 8.26±0.64, 
WT = 7.2±0.45) or the number of neurites per 
cell body (KO = 3.82±0.18, WT = 3.53±0.20) 
(data not shown). However, we were able to 
observe a substantial enlargement in the growth 
cone area of Nogo-A KO neurons (KO = 
168.2±16.71, WT = 102.30±10.94) (Fig. 7 C), as 
well as a major increase in the number of actin 
filopodia emitted from both the growth cone (KO 
= 21.41±1.07, WT = 11.93±0.51) and the cell 
body (KO = 22.43±1.17, WT = 16.65±8.61) (Fig. 
7 C). Furthermore, these filopodia were 
significantly longer (KO = 5.31±0.22, WT = 
3.79±0.17) (Fig. 7 C). These data further support 
a role of neuronal Nogo-A in actin cytoskeleton 
remodeling. 
Increased growth cone motility in Nogo-A KO 
adult dissociated DRG neurons  - To observe 
whether the changes on the morphological level 
shown in growth cones of Nogo-A KO neurons 
could also cause a functional modification in 
growth cone motility we used time-lapse 
microscopy (Suppl. Video 1 and 2).  As expected 
from the previous results, we found a clear 
increase in the mean area of growth cones of 
Nogo-A KO DRG neurons (initial area = 
96.6±9.9 um2, final area = 105.5±10.6 um2 over a 
15min observation period) compared to WT ones 
(initial area = 54.6±5.4 um2, final area = 
61.1±5.3 um2) (Fig. 8 A). Furthermore, in 15min 
Nogo-A KO growth cones covered double the 
distance (KO = 8.9±0.9 um, WT = 4.3±0.7 um) 
covered by WT growth cones, showing a strong 
increase in growth speed (Fig. 8 B). Nogo-A KO 
growth cones showed higher minimum speed 
(KOmin = 0.16 um/min, WTmin = 0.00 um/min) 
as well as higher maximum speed (KOmax = 
1.38 um/min, WTmax = 0.94 um/min). This 
increase was not due to a continuous 
enlargement over time in the area of Nogo-A KO 
growth cones or a restriction of WT ones, as 
initial and final area for each genotype were not 
statistically different (Fig. 8 A). To test whether 
the observed speed difference was a secondary 
effect caused by different turning behavior of 
KO compared to WT growth cones, the rotation 
angle was measured but no significant difference 
was observed (Suppl. Fig. 3). If Nogo-A KO 
growth cones advance more rapidly, longer 
neurites could be expected. We measured the 
total length of the neuritic tree of WT and Nogo-
A KO adult dissociated DRG neurons after 1, 2 
and 3DIV. The increase in growth cone area and 
speed did translate into a significant increase in 
the overall size of the neuronal tree (Fig. 8 C).  
Inhibition of LIMK1 activity decreases growth 
cone motility in Nogo-A KO adult dissociated 
DRG neurons - A recent study from Endo et al 
(2007) found that a cell-permeable peptide 
containing the N-terminal sequence of cofilin 
and therefore its Ser3 phosphorylation site (S3-
peptide) inhibits LIMK1 activity and reduces p-
cofilin levels in the growth cone of chick DRG 
neurons. We confirmed that the S3-peptide, but 
not the reverse control peptide (RV-peptide), can 
decrease cofilin phosphorylation and F-actin in 
vitro in native COS-7 cells (Suppl. Fig. 4), NGF-
primed PC12 cells, and retinal ganglion neurons 
(Fig. 9). To test whether the activity of LIMK1 
could be directly responsible for the increased 
growth cone motility observed in Nogo-A KO 
adult DRG neurons, we inhibited LIMK1 in 
Nogo-A KO as well as WT dissociated DRG 
neurons. Time-lapse video analysis of S3-peptide 
treated KO cultures showed clearly reduced 
growth cone motility when compared to the 
control peptide (RV) treated Nogo-A KO cells 
(KO S3-peptide treated grew 6.93±0.93 um in 15 
min; KO RV-peptide treated growth cones grew 
10.45±0.88um in 15 min) (Fig. 10 A). The 
inhibition of LIMK1 in WT dissociated DRG 
neuronal cultures with S3 peptide did not 
produce a significant decrease in growth cone 
motility when compared to control RV peptide 
(WT S3-peptide treated grew 5.56±0.63 in 
15min; WT RV-peptide treated growth cones 
grew 5.59±0.79 in 15min) (Fig. 10 B). The 
inhibition of LIMK1 thus reversed almost 
completely the KO phenotype to the levels of 
growth cone extension length observed for WT 
neurons, speaking for a role of the 
LIMK1/cofilin pathway in the observed 
phenotype. 
 
DISCUSSION 
 
Molecular reorganization of the neurite 
outgrowth machinery in the intact adult nervous 
system of Nogo-A KO mice - Nogo-A KO mice 
have been extensively studied as regeneration 
model following a CNS lesion (Dimou et al., 
2006; Kim et al., 2003; Simonen et al., 2003; 
Zheng et al., 2003) but the possible functions of 
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Nogo-A in the intact CNS are still rather unclear. 
Therefore in this study, we addressed this 
question using a double proteomics approach to 
investigate the molecular changes in the adult 
intact nervous system of Nogo-A KO mice. In 
line with previous reports of enhanced sprouting 
and fiber growth following antibody-mediated 
Nogo neutralization in the unlesioned rat adult 
CNS (Bareyre et al., 2002; Buffo et al., 2000), in 
our study a reorganization and enhancement of 
the Nogo-A KO neuronal growth machinery both 
on the molecular and morphological level could 
be observed. 
We found that a large proportion of differentially 
expressed proteins in the Nogo-A KO intact 
adult nervous system were components of the 
cytoskeleton, cytoskeleton binding proteins, 
signaling molecules involved in cytoskeleton 
remodeling and growth, early neurite growth 
markers and axonal transport constituents. 
Numerous proteins which are known to play an 
important role in actin and tubulin cytoskeleton 
remodeling (e.g. F-actin binding protein, dynein, 
myosin, and tropomyosin) were found to be 
regulated in a direction pointing to growth 
enhancement: downregulation of actin-severing 
proteins and upregulation of motor as well as 
structural proteins. The regulation of many 
neuron specific cytoskeletal proteins, in 
particular neurofilament-68, peripherin and a-
internexin which are highly expressed during 
development and in early neurite formation, as 
well as of other neuronal markers, such as 
MAP2, strongly suggests that not only the 
cytoskeleton but more specifically the neuronal 
outgrowth machinery is affected. This hypothesis 
is also supported by the signaling pathways that 
were found to be regulated: most of these 
components are known to affect neuronal 
cytoskeleton dynamics as well as growth cone 
motility, especially the 14-3-3 family of proteins 
(Sarmiere & Bamburg, 2004; Soosairajah et al, 
2005), the CRMP-signaling pathway (Arimura et 
al, 2006) and the Rho-GTPases-signaling 
pathways (Huber et al, 2003). In line with the 
observed regulation of the Rho-GTPase-
signaling pathway, we found another molecule, 
which has been suggested by Hsieh et al (2006) 
to be downstream of Nogo-A signaling, being 
regulated in the CNS tissue of Nogo-A KO mice: 
cofilin. The Rho-GTPase signaling pathway can 
affect the phosphorylation state of LIMK1 which 
can phosphorylate and inactivate cofilin 
(Bernard, 2007). We observed two spots being 
regulated for cofilin in the 2DE approach (0.79 (-
1.27) and 1.70 fold, respectively) (Table 1), 
while the ICAT data showed only a slight 
downregulation in its total level (Table 2). 
Western blot analysis in a separate set of animals 
confirmed the increase in cofilin phosphorylation 
but did not show significant changes in its total 
level, probably due to high inter-individual 
variability. These data pointed to the potential 
regulation of cofilin activity through 
phosphorylation in the intact adult nervous 
system of Nogo-A KO mice. Therefore the Rho-
GTPase/LIMK1/cofilin signaling pathway is a 
candidate in the regulation of neuronal 
cytoskeletal proteins in the absence of Nogo-A 
signaling. 
Increased growth cone motility in Nogo-A KO 
neurons through the LIMK1/cofilin pathway - 
The analysis of the observed regulated signaling 
pathways in our proteomic approach had 
highlighted the Rho-GTPases/LIMK1/cofilin 
signaling pathway as a potential, even if not 
unique, candidate in the regulation of neuronal 
cytoskeletal proteins in the absence of Nogo-A 
signaling. Our experiments further supported it: 
the western-blot analysis showed increased 
levels of phosphorylated LIMK1 as well as 
cofilin in the intact adult spinal cord of Nogo-A 
KO mice. Moreover, LIMK1 phosphorylation 
was upregulated in growth cones of DRG 
neurons dissected from adult Nogo-A KO mice. 
LIMK1 phosphorylation depends on the activity 
of ROCK, regulated by GTP-bound Rho, and of 
PAK1, regulated by Rac and Cdc42. 
Interestingly, Nogo-A is already known to 
modulate Rho-A activity. Our data confirm a role 
for Rho activation in Nogo-A mediated neuronal 
cytoskeleton rearrangements, as an increase in 
activated GTP-bound Rho could be observed in 
growth cones of Nogo-A KO neurons. Cofilin is 
inactivated by phosphorylation at Ser3 by active 
LIMK and is known as an essential regulator of 
actin dynamics through its filament severing 
activity (Sarmiere et al, 2004; Endo et al, 2007). 
Its high expression at the growth cone has 
pointed to its possible involvement in the 
regulation of growth cone motility: cofilin 
increased the length of neurite outgrowth when 
expressed in rat cortical neurons in primary 
cultures (Meberg & Bamburg, 2000), suggesting 
that it plays a critical role in neurite extension 
and growth cone motility. A recent study by 
Endo et al (2007) found that a cell-permeable 
cofilin fragment (S3-peptide), containing the 
Ser3 phosphorylation site, binds to and inhibits 
the endogenous LIMK1 activity. The resulting 
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reduced endogenous p-cofilin levels in the 
growth cones suppressed growth cone motility 
and extension in chick DRG neurons, suggesting 
that LIMK1 stimulates neurite extension through 
its cofilin-phosphorylating activity. Plus, it has 
been shown that LIMK1 activation state can 
influence dendritogenesis as well (Lee-Hoeflich 
et al, 2004). Due to all these numerous 
observations, the observed modulation of the 
LIMK1/cofilin pathway in the adult spinal cord 
of unlesioned adult Nogo-A KO mice and at the 
growth cone of adult Nogo-A KO neurons could 
influence growth cone morphology, motility, and 
neurite outgrowth. In point of fact, we observed 
that growth cones of adult Nogo-A KO DRG 
neurons are larger and more motile compared to 
WT ones. Moreover, the increase in the growth 
cone area is due to an enlargement of 
lamellipodia but not of the microtubule 
containing core of the growth cone, pointing to a 
key role of the actin cytoskeleton and to its 
modulation. The increase in growth cone motility 
translated in long term cultures, as previously 
described (Dimou et al, 2006), into a noticeably 
increased neuronal total outgrowth. The 
specificity of the observed phenotype was 
confirmed by its reproducibility by antibody-
mediated acute neuronal Nogo-A neutralization 
in adult WT DRG neurons, and by its 
reproducibility in postnatal Nogo-A KO 
dissociated DRG neurons. These results point to 
neuronal Nogo-A as major contributor to the 
observed phenotype and highlight the specificity 
of the observed effects, which could be, 
otherwise, attributed to the regulation of 
compensating molecules, like Nogo-B which has 
been described being highly upregulated in 
Nogo-A KO mice (Dimou et al, 2006).  
More evidence of a direct link between the 
observed phenotype of increased growth cone 
motility and the observed regulation of the 
LIMK1/cofilin pathway was brought by the fact 
that the presence of the S3-peptide, which 
activated cofilin by decreasing its 
phosphorylation, caused the reversion of the 
observed phenotype in vitro in Nogo-A KO 
growth cones: they moved at lower speed, which 
was comparable to that of WT growth cones.  
Summary – The present study provides 
mechanistic insights into the function of neuronal 
Nogo-A in the unlesioned CNS and the related 
molecular signaling pathways. Our results 
suggest that Nogo-A might act as neuronal local 
growth suppressor in the intact nervous system, 
both in adulthood and during development: its 
ablation causes modulation of Rho-GTP and of 
the LIMK1/cofilin pathway, through 
phosphorylation regulation, which leads to actin 
cytoskeleton remodeling, increased growth cone 
motility and neurite outgrowth in an intact 
system. In conclusion, we suggest that neuronal 
Nogo-A could play a role in the fine regulation 
of neuronal growth control through growth cone 
motility modulation in the intact adult as well as 
developing nervous system.
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FIGURE LEGENDS 
 
Fig. 1 Protein expression changes in adult Nogo-A KO versus WT mouse spinal cord as 
shown by 2D-gels. Representative images showing spinal cord proteins of WT and Nogo-A 
KO mice, separated on pH 3-10 isoelectrophocusing strips and 11% SDS-page 2-dimensional 
gels. Percentage of identified proteins per total identified proteins and spots in each functional 
category (calculated from the total number of proteins (62) and spots (93), respectively) 
differentially expressed in Nogo-A KO versus WT adult spinal cord. Assignment to 
functional categories was made on the basis of GeneOntology and literature mining.  
 
Fig. 2 Quantitative proteomic analysis of Nogo-A KO versus WT adult mouse spinal cord by 
ICAT analysis. (A) Number of identified proteins (505, 479, 458, 438, 407, 303) according to 
different ProteinProphet probability scores (from ≥0.5 to =1.0). (B) Logarithmic distribution 
of the number of identified proteins (407 proteins total, p≥0.9) as a function of the observed 
fold change values. The data presented a normal distribution around a mean ratio of 
1.19±0.02; this value was used to normalize the fold change values. (C) Percentage of 
proteins in each functional category differentially expressed in Nogo-A KO versus WT adult 
spinal cord. Assignment to functional categories was made on the basis of “Panther” analysis 
(www.panther.org) and literature mining.  
 
Fig. 3 Suggested molecular model for the observed changes in growth cone motility in Nogo-
A KO neurons. Upregulation of phosphorylated, active, LIMK, due to the upregulation of 
Rho-GTPases signaling activity, is translated into downstream phosphorylation and therefore 
deactivation of the actin severing protein cofilin. This deactivation is further supported by 
downregulation of PP1, one of the players responsible for the turnover of p-cofilin into active 
cofilin, as well as by the upregulation of 14-3-3 proteins, which can stabilize phosphorylated 
cofilin. Cofilin inactivation coupled to the downregulation of actin polymerization impeding 
factors, like F-actin capping protein, allows the increase in actin polymerization required for 
the formation of new actin filopodia and for the extension of the growth cone. This process is 
further supported by the downregulation of myosin II which is responsible for the retrograde 
flow of G-actin. These changes could be further influenced by the downregulation of CRMP2  
and CRMP5, whose signal is involved in growth cone collapse response (Charrier et al., 2003; 
Quach et al., 2004). The enhancement of the neurite outgrowth machinery is supported by the 
regulation of specific neurofilaments, e.g. NF68, α-internexin, MAP2, Peripherin. 
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Fig. 4 Modulation of the LIMK1/cofilin pathway in the adult spinal cord of Nogo-A KO 
mice. (A, B) Representative images of Western blots and corresponding densitometric 
quantification reporting the level of expression of phosphorylated cofilin and total cofilin (A), 
and phosphorylated LIMK1 and total LIMK1 (B) in spinal cord lysates from WT and Nogo-A 
KO mice. Results show increased phosphorylation of cofilin and of the cofilin-regulator 
LIMK1 in the spinal cord of adult unlesioned Nogo-A KO mice. Protein levels have been 
normalized to the expression levels of GAPDH (n=8; Mann-Whitney test, *, p<0.05).  
 
Fig. 5 Regulation of Rho-GTP, LIMK1 and p-LIMK1 at the growth cones of Nogo-A KO 
neurons. (A) Representative immunofluorescence images showing p-LIMK1-Cy3 and total-
LIMK-Cy3 staining in growth cones of WT and Nogo-A KO adult dissociated DRG neurons, 
cultured for 14hours and densitometric quantification of staining intensity. For each growth 
cone F-actin staining with phalloidin-Alexa488 and merged images are also shown. Results 
show increased phosphorylation of LIMK1 but no increase in the total protein level. The data 
have been normalized to the mean of the WT values (n=20 per group; Mann-Whitney test, *, 
p<0.05). Scale bars, 10um. Error bars represent SEM. IgG-Cy3 (control) did not show any 
specific staining. (B) Representative immunofluorescence images showing Rho-GTP-bound-
Cy3 staining (Rhotekin) in growth cones of WT and Nogo-A KO adult dissociated DRG 
neurons, cultured for 14hours, and densitometric quantification of staining intensity. Results 
show increase in Rho-GTP in Nogo-A KO growth cones. The data have been normalized to 
the mean of the WT values (n=20 per group; Mann-Whitney test, ***, p<0.0001). Scale bars, 
10um. 
 
Fig. 6 Adult neurons from Nogo-A KO mice show altered growth cone morphology and 
motility. (A) Representative examples of dystrophic (Tom, 2004), normal and enlarged 
growth cones as observed in WT and Nogo-A KO adult dissociated DRG neurons labeled for 
microtubules (anti-beta-tubulin-Cy3 (Red)) and F-actin (Phalloidin-Alexa488 (Green)). 
Distribution of WT and KO growth cones according to their areas (<50um2, 50-100um2 and 
≥100um2). Percentage of WT and Nogo-A KO neurons showing enlarged growth cones, 
calculated for the total number of evaluated neurons in 3 independent experiments (Mann-
Whitney test, ***, p<0.0001). Error bars represent SEM.  (B)  Analysis of lamellipodia and 
filopodia in growth cones of Nogo-A KO and WT adult dissociated DRG neuron. Data have 
been normalized to the mean of the WT values (n=50 per group, two independent 
experiments; Mann-Whitney test, **, p<0.001, ***, p<0.0001). 
 
Fig. 7 Antibody mediated-neutralization and genetic ablation of neuronal Nogo-A affects 
growth cone morphology. (A) Western blots showing the specific detection of one single 
band corresponding to the expected MW for Nogo-A, with anti-Nogo-A mouse monoclonal 
11C7 antibody, in spinal cord lysates from WT and Nogo-A KO mice. (B) Percentage of WT 
and Nogo-A KO neurons showing enlarged growth cones, WT NT (non-treated) and WT IgG 
as control treatments. Percentage calculated for the total number of evaluated neurons (nj≥20) 
in 3 independent experiments (n=3; Mann-Whitney test, ***, p<0.0001. Error bars represent 
SEM). (C) Genetic ablation of Nogo-A influences growth cone morphology also of P0 DRG 
neurons. Representative images of Nogo-A KO and WT newborn dissociated DRG neurons, 
after 6 hours in cultures. Immunofluorescence labeling with anti-beta-tubulin-Cy3 (red) and 
phalloidin-Alexa-488 (green). Scale bar 10um. Quantification of the area of Nogo-A KO and 
WT growth cones (Mann-Whitney test, ***, p<0.0001. Error bars represent SEM).  
 
Fig. 8 Increased neurite outgrowth of Nogo-A KO dissociated DRG neurons. (A) Following 
13 hours in cultures, growth cones were filmed over 15min. The first (t = 0min) and last (t = 
15min) frame of each movie for both Nogo-A KO and WT growth cones have been traced 
with separate colors (first = green, last = red). Growth cone areas are shown in the 
corresponding bar graph (Mann-Whitney test, ***, p<0.0001, **, p<0.001. Error bars 
represent SEM. 6 independent experiments.). The initial (i) and final (f) tracings have been 
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then overlapped for further analysis. (B) The arrows show the measured length of growth 
cone extension during the 15 min of recording. The mean lengths of growth cone extension 
are shown in the bar graph (Mann-Whitney test, ***, p<0.0001. Error bars represent SEM). 
(C) Representative images of WT and Nogo-A KO adult dissociated DRG neurons, 3DIV, 
immunofluorescently labeled with anti-tubulin-betaIII-Cy3. Scale bar 50um. The total length 
of the neurite tree was measured by Metamorph software after 1, 2, and 3DIV in culture (t-
test, *, p<0.05, ***, p<0.0001. Error bars represent SEM). 
 
Fig. 9 S3-peptide treatment reduces p-cofilin and F-actin immunostaining in NGF-
differentiated PC12 cells and retinal ganglion neurons. (A) Representative 
immunofluorescence images of PC12 cells, differentiated via NGF, treated for 1 hour with 20 
ug/ml of S3- or the reverse-sequence control RV-peptide. Immunofluorescence labeling with 
phalloidin-Alexa488 (green) and p-cofilin-Cy3 (red). Scale bar 20um. Quantification by 
densitometry of p-cofilin and F-actin staining intensity following treatment with increasing 
concentrations (5, 10, 20, 40 ug/ml) of S3- or the reverse-sequence control RV-peptide. The 
data have been normalized to the mean of the RV-treated PC12 cells values (n=20 per group; 
3 independent experiments; Mann-Whitney test, ***, p<0.0001. Error bars represent SEM). 
(B) Representative immunofluorescence images of retinal ganglion neurons, treated for 1 
hour with 20 ug/ml of S3- or the reverse-sequence control RV-peptide. Immunofluorescence 
labeling with phalloidin-Alexa488 (green) and p-cofilin-Cy3 (red). Scale bar 20um. 
Quantification by densitometry of p-cofilin and F-actin staining intensity following treatment 
with 20ug/ml of S3- or the reverse-sequence control RV-peptide. The data have been 
normalized to the mean of the RV-treated cells values (n=20 per group; 3 independent 
experiments; Mann-Whitney test, ***, p<0.0001. Error bars represent SEM). 
 
Fig. 10 Inhibition of LIMK1 activity decreases growth cone motility in Nogo-A KO adult 
dissociated DRG neurons (A, B) Dissociated DRG neurons from adult Nogo-A KO (A) or 
WT (B) mice were grown 13hours on a poly-lysine and laminin substrate. Cultures were 
treated for 1 hour with 20ug/ml S3- or RV-peptide and growth cones were then filmed over 
15min. Representative images of the first (f) (t=0min) and last (l) (t=15min) frame for S3- and 
RV- treated cultures are shown. Dashed lines show growth cone position at time point 0 while 
full lines show growth cone position after 15 min imaging. Scale bar 20um. The mean lengths 
of growth cone extension, corresponding to the distance between dotted and full lines, are 
shown in the bar graph (quantified growth cones n≥30; 6 independent experiments; Mann-
Whitney test, ***, p<0.0001. Error bars represent SEM). 
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Table 1. 2DE spots differentially expressed in the spinal cord of Nogo-A KO versus WT mice 
in the categories Cytoskeleton and Signaling 
 
Spot ID    
Number Protein
1 mean  fold change 
(p≤0.05) IPG strip 
CYTOSKELETON 
1837 Actin (Beta, Gamma, Alpha) 0.76 4-7 
1926 Alpha centractin (Actin related protein 1) 1.22 4-7 
2032 Alpha internexin (66kDa filament) 0.052 4-7 
2155 Alpha internexin (66kDa filament) 20.002 4-7 
2147 Alpha internexin (66kDa filament) 20.002 4-7 
4102 Cofilin, non-muscle isoform      (Cofilin-1) 0.79 3-10 
4180 Cofilin, non-muscle isoform      (Cofilin-1) 1.70 3-10 
4173 GFAP 1.50 3-10 
4505 GFAP 20.002 3-10 
4526 GFAP 20.002 3-10 
3951 GFAP 1.92 3-10 
4502 GFAP 20.002 3-10 
4058 GFAP 1.50 3-10 
1864 GFAP 2.94 4-7 
2027 GFAP 0.60 4-7 
2038 GFAP 0.052 4-7 
2018 GFAP 0.60 4-7 
4007 Neurofilament-68 0.63 3-10 
4339 Neurofilament-68 0.052 3-10 
1679 Neurofilament-68 0.62 4-7 
1674 Neurofilament-68 0.62 4-7 
1753 Neurofilament-68 1.50 4-7 
4119 Myosin regulatory light chain 2, skeletal muscle isoform 0.46 3-10 
4333 Myosin regulatory light chain 2, skeletal muscle isoform 0.05
2 3-10 
1678 Peripherin 1.25 4-7 
1776 Tropomyosin alpha chain (Tropomyosin 1) 0.61 4-7 
4261 Tropomyosin beta chain (Tropomyosin 2) 0.27 3-10 
1914 Tubulin alpha 0.78 4-7 
1870 Tubulin alpha 1.50 4-7 
1908 Tubulin beta chain 0.75 4-7 
2012 Tubulin beta chain 0.69 4-7 
SIGNALING 
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2621 14-3-3 protein beta/alpha (PKC inhibitor protein 1.34 4-7 
1774 14-3-3 protein tau (14-3-3 protein theta) 0.46 4-7 
4347 Acidic FGF (FGF-1) 0.052 3-10 
3931 Astrocytic phosphoprotein PEA-15 1.50 3-10 
1881 Dihydropyrimidinase related protein 2 (CRMP2) 0.90 4-7 
1681 Guanine nucleotide-binding protein (Transducin alpha chain) 2.00 4-7 
2164 Guanine nucleotide-binding protein (Transducin beta chain 2) 20.00
2 4-7 
4020 Rho GDP-dissociation inhibitor (GDI) 1 (alpha) 1.55 3-10 
4521 Rho GDP-dissociation inhibitor (GDI) 1 (alpha) 20.00
2 3-10 
1748 Serine/Threonine protein phosphatase 2A 1.80 4-7 
 
1 Spots corresponding to statistically significant (1way-Anova test p≤0.05; normalization per 
gel as well as to the median of the 3 biological replicate gels; call (present/absent) filter (2 out 
of 3 biological replicates WT and/or KO) was applied) regulated cytoskeletal and signaling 
proteins.  
2 Spots present only in KO or WT protein lysates were assigned the arbitrary values of 20 
(20-fold increase; present only in the KO) or 0.05 (20-fold decrease; present only in the WT).  
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Table 2. Differentially expressed Cytoskeleton and Signaling proteins in the spinal cord of 
Nogo-A KO versus WT mice by ICAT. Proteins found regulated also by 2DE have been 
highlighted. Applied threshold for protein probability (p) score was p≥0.9.  
 
P DESCRIPTION 
Adjusted 
ratio 
mean 
Adjusted 
ratio std 
dev 
CYTOSKELETON 
1 Transgelin-3 2.04  0.22  
1 Tetraspanin-2 0.34  0.11  
1 Splice Isoform 2 of AP-2 complex subunit beta-1,Splice 
Isoform 1 of AP-2 complex subunit beta-1 
0.19  0.04  
1 PREDICTED: similar to Cofilin-1 (Cofilin, non-muscle 
isoform) isoform 1 
0.66  0.27  
0.98 PREDICTED: microtubule-associated protein (MAP2) 2.05  0.62  
1 Microtubule-associated protein RP\EB family member 3 1.81  0.59  
1 Lap3 protein 0.29  0.06  
1 In vitro fertilized eggs cDNA, RIKEN full-length enriched 
library, clone:7420442C15 product: actin, gamma, 
cytoplasmic, full insert sequence, Bone marrow 
macrophage cDNA, RIKEN full-length enriched library, 
clone:I830072C08 product: actin, beta, cytoplasmic, full 
insert sequence, Actin, cytoplasmic 1,Actin, cytoplasmic 2 
1.23  0.22  
1 Impact protein 0.72  0.21  
1 F-actin capping protein alpha-2 subunit 0.69  0.15  
1 Cytoplasmic dynein heavy chain, Dynein heavy chain, 
cytosolic 
15.54  5.64  
1 Complexin-1 1.72  0.30  
1 AP-2 complex subunit alpha-2 1.57  0.43  
1 117 kDa protein, Ankyrin 2, brain 0.35  0.06  
SIGNALING 
1 Splice Isoform 2 of 14-3-3 protein theta, Splice Isoform 1 
of 14-3-3 protein theta 
1.70  0.55  
1 Rho-related GTP-binding protein RhoB precursor 0.34  0.12  
1 Ras-related protein Rab-3D 0.22  0.06  
0.99 PREDICTED: similar to 14-3-3 protein eta,14-3-3 protein 
eta 
1.48  0.30  
0.98 PREDICTED: hypothetical protein LOC75471,GTP-
binding nuclear protein Ran, testis-specific isoform, GTP-
binding nuclear protein Ran 
0.50  0.13  
1 Mammary gland RCB-0527 Jyg-MC(B) cDNA, RIKEN 
full-length enriched library, clone:G930005L08 product: 
RAS-related C3 botulinum substrate 1, full insert sequence 
0.68  0.23  
1 Guanine nucleotide-binding protein G(o), alpha subunit 
2,Guanine nucleotide-binding protein G(o), alpha subunit 1
0.69  0.19  
1 Guanine nucleotide-binding protein G(I)\G(S)\G(T) beta 
subunit 2 
0.71  0.09  
1 Dihydropyrimidinase-related protein 5,62 kDa protein 
(CRMP5) 
0.72  0.24  
1 14-3-3 protein gamma 1.28  0.25  
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